Purple Biotech
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -64 | -53 | -58 | -48 |
EBITDA | -2,180 | -2,928 | -1,315 | -1,214 |
EBIT | -2,244 | -2,981 | -1,373 | -1,262 |
Net Income | -85 | -23,692 | -1,309 | -1,108 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,121 | -1,070 | -1,065 | -1,546 |
Cash | 5,567 | 8,716 | 9,592 | 4,736 |
Basic Shares | 4 | 2 | 284 | 273 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $195 | $-910 |
Gross Profit | -204 | -186 | ||
EBITDA | -26,250 | -7,052 | -19,875 | -21,492 |
EBIT | -26,453 | -7,238 | -19,921 | -21,693 |
Net Income | -26,386 | -7,240 | -19 | -21,668 |
Net Change In Cash | 0 | 0 | 195 | -910 |
Free Cash Flow | -5,539 | -14,367 | -19,928 | -16,963 |
Cash | 8,716 | 7,401 | 14,489 | 15,030 |
Basic Shares | 2 | 163 | 110 | 90 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$2.32 |
2025-12-31 | -$6.16 |
2025-09-30 | $2.90 |
2025-06-30 | -$4 |